Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
04/2004
04/28/2004EP1411965A1 Methods and compositions for controlling protein assembly or aggregation
04/28/2004EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
04/28/2004EP0805822B1 Spray dried erythropoietin
04/28/2004CN1492926A Preferred segments of neural thread protein and methods of using the same
04/28/2004CN1491964A Process for purifying hematoglobin
04/28/2004CN1491961A Amaranth seed ribosome inactivating protein
04/28/2004CN1147305C Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof
04/27/2004US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors
04/27/2004US6727070 Protein/solubility folding assessed by structural complementation
04/27/2004US6727062 Identification of target structures E.G. in vivo selection method for a phage library
04/27/2004US6726880 Device comprising support substrate, array of microlocations comprising electronically addressable electrodes, two collection electrodes adjacent to opposite sides of array, and flow cell adapted to be supported on substrate
04/27/2004CA2096888C Process for the inactivation of viruses in preparations of proteins
04/22/2004WO2004033488A2 Peptide mediated synthesis of metallic and magnetic materials
04/22/2004WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase
04/22/2004WO2004032599A2 Novel immunogenic proteins of leptospira
04/22/2004WO2003096985A3 3d structure of the tsg101 uev domain
04/22/2004WO2003044042A9 Site selective acylation
04/22/2004WO2003039346A8 Diagnostics and therapeutics for ocular abnormalities
04/22/2004US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings
04/22/2004US20040077838 Methods to inhibit the formation of colouring components and to reduce the presence of materials tending to form colouring components to obtain a lighter and less yellow canola protein isolate
04/22/2004US20040077836 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
04/22/2004US20040077830 Method for synthesizing peptides comprising at least one glycine molecule
04/22/2004US20040077827 Process for the synthesis of a peptide having a trp residue
04/22/2004US20040077826 Randomly generated glycopeptide combinatorial libraries
04/22/2004US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release
04/22/2004US20040077541 Methods of using non-human animal Apolipoprotein A-I protein
04/22/2004US20040077532 Aglyco products and methods of use
04/22/2004US20040077528 Entrapping active agent in fumaryl diketopiperazine derivative and solvent washing out impurities; purified insulin for pulmonary administration
04/22/2004US20040077527 Purified insulin composition
04/22/2004US20040077522 Machine readable media embedded with three dimensional atomic coordinates; drug design
04/22/2004US20040077074 Multi-chambered analysis device
04/22/2004US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides
04/22/2004US20040077037 Regiospecific modification of peptides and proteins with probes and reporter molecules using peptidases in combination with a non-amino acid- like or non-peptide-like substrate mimetic
04/22/2004US20040076623 Biochemical immobilization, immobilized enzyme, resin peptides, for solid phase synthesis; a benzaldehyde polystyrene lantern, coupled to streptavid or horseradish peroxidase
04/22/2004DE10248123A1 Preparation of properly folded ion channels, useful e.g. for identifying specific ligands, by dissolving recombinant subunits in first detergent solution then exchange to second detergent to induce folding
04/22/2004CA2820949A1 Novel immunogenic proteins of leptospira
04/22/2004CA2501939A1 Novel immunogenic proteins of leptospira
04/22/2004CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase
04/22/2004CA2499318A1 Peptide mediated synthesis of metallic and magnetic materials
04/21/2004EP1411063A1 Peptide nucleic acids
04/21/2004EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application
04/21/2004EP1409709A2 A method for improving recombinant protein stability and solubility
04/21/2004EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
04/21/2004EP1409667A2 Process for preparing variant polynucleotides
04/21/2004EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof
04/21/2004EP1409459A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
04/21/2004EP1409128A2 Method and assembly for attaching substances that have been immobilised in transport agents and monomer particles
04/21/2004EP1409126A1 Method and apparatus for continuous processing of organic material
04/21/2004EP1408770A2 Gelling vegetable protein
04/21/2004EP1257577B1 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
04/21/2004EP1117678B1 Solid phase synthesis, whereby the solid phase consists of two different substrates
04/21/2004EP1007065B1 Preparation of collagen
04/21/2004EP0856007B1 Cyclopeptide derivatives
04/21/2004EP0714406B1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i
04/21/2004CN1490405A Method for preparing lysozyme
04/21/2004CN1490334A Affinity purifying method for gene specific antibody
04/21/2004CN1490327A Synthesis and apparatus for high-flux polypeptide
04/20/2004US6723831 Removal antibodies from body fluids
04/20/2004US6723699 Administering as cholinergic agent to treat nervous system disorders
04/20/2004US6723510 Methods for separating particulate substrates from solution while minimizing particle loss
04/20/2004US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures
04/20/2004CA2250784C Reactor and method for solid phase peptide synthesis
04/15/2004WO2004031226A1 Immunogenic library of chimeric peptides mimicking the genetic diversity of the hypervariable region v3 of the protein of the envelope of a virus gp 120 of human immunodeficiency
04/15/2004WO2004031215A2 Method for synthesizing peptides comprising at least one glycine molecule
04/15/2004WO2004031213A1 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
04/15/2004WO2004031212A1 Antigenic peptides
04/15/2004WO2004031205A2 Use of trichloroacetimidate linker for peptide synthesis
04/15/2004WO2004030521A2 Use of biomarkers for detecting acute renal transplant rejection
04/15/2004WO2004022630A3 Water-soluble polymer alkanals
04/15/2004WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response
04/15/2004WO2003095619A3 Protein complex purification
04/15/2004WO2003091266A3 Protein stabilisation using chaperone proteins
04/15/2004WO2003040094A9 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein
04/15/2004WO2003020767A9 Antibodies against caspase-8, their preparation and use
04/15/2004WO2001019852A8 Methods of peptide preparation
04/15/2004US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
04/15/2004US20040072738 Analogues of thiocoraline and be-22179
04/15/2004US20040072322 Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
04/15/2004US20040072314 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone
04/15/2004US20040072282 Preparing g-protein coupled receptor fragment for identifying modulators of signal tranduction and drug therapeutics
04/15/2004US20040072236 PrPSc -interacting molecules and uses thereof
04/15/2004US20040071968 Porous compositions comprising surface modified monoliths
04/15/2004US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH)
04/15/2004US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid
04/15/2004US20040069710 Method and apparatus for isolation and purification of biomolecules
04/15/2004US20040069707 Method of isolating a charged compound
04/15/2004US20040069631 Method and device for carrying out 2d electrophoresis in large gels
04/15/2004CA2500401A1 Antigenic peptides
04/14/2004EP1407269A2 A method for diagnosing a person having multiple sclerosis
04/14/2004EP1407019A2 Intestinal proteins
04/14/2004EP1406919A2 Method for electrophoretically separating membrane proteins
04/14/2004EP1406918A1 The production of soluble keratin derivatives
04/14/2004EP1406636A2 System and method for the large scale labeling of compounds with radiohalogens
04/14/2004EP1406493A1 Administration of agents via the pept-2 transporter
04/14/2004EP1257571B1 Method of purifying a hydrophobin present in a hydrophobin-containing solution
04/14/2004EP1235854A4 Method of separating prions from biological materials
04/14/2004EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
04/14/2004CN1488753A Gene-expressed human tissue kallikrein protein separating and purifying method
04/14/2004CN1488752A Method for extracting peroxidase from longan pericarp
04/14/2004CN1488645A Specific antibody IgY for anti SARS virus, and preparing method thereof and composition containing same and its use